Join Growin Stock Community!

Aimei health technology co., ltdAFJKR.US Overview

US StockIndustrials
(No presentation for AFJKR)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

AFJKR AI Insights

AFJKR Overall Performance

AFJKR AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

AFJKR Recent Performance

3.24%

Aimei health technology co., ltd

-1.72%

Avg of Sector

-2.16%

S&P500

AFJKR PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

AFJKR Key Information

AFJKR Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

AFJKR Profile

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Price of AFJKR

AFJKR FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

AFJKR Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.05
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
100.00%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.05
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
100.00%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is AFJKR's latest earnings report released?

    The most recent financial report for Aimei health technology co., ltd (AFJKR) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating AFJKR's short-term business performance and financial health. For the latest updates on AFJKR's earnings releases, visit this page regularly.

  • Where does AFJKR fall in the P/E River chart?

    According to historical valuation range analysis, Aimei health technology co., ltd (AFJKR)'s current price-to-earnings (P/E) ratio is 41.56, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • How much cash does AFJKR have?

    At the end of the period, Aimei health technology co., ltd (AFJKR) held Total Cash and Cash Equivalents of 2.14K, accounting for 0 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is AFJKR's EPS continuing to grow?

    According to the past four quarterly reports, Aimei health technology co., ltd (AFJKR)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.03. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of AFJKR?

    Aimei health technology co., ltd (AFJKR)'s Free Cash Flow (FCF) for the period is -224.01K, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 34.16% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of AFJKR?

    The latest valuation data shows Aimei health technology co., ltd (AFJKR) has a Price-To-Earnings (PE) ratio of 41.56 and a Price/Earnings-To-Growth (PEG) ratio of -0.99. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.